Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 9 Neoplasms 7 Breast Neoplasms 6 Pancreatic Neoplasms 3 Malnutrition 3 Laryngeal Neoplasms 3 Head and Neck Neoplasms 3 Prostatic Neoplasms 2 Pharyngeal Neoplasms 2 Obesity 2 Lung Neoplasms 2 Liver Neoplasms 2 Diabetes Mellitus, Type 2 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Weight Loss 1 Undefined 1 Stomach Neoplasms 1 Skin Neoplasms 1 Sarcopenia 1 Rectal Neoplasms 1 Pancreatitis, Chronic 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neurotoxicity Syndromes 1 Mouth Neoplasms 1 Lung Diseases 1 Liver Diseases 1 Hypopharyngeal Neoplasms 1 Hematologic Neoplasms 1

Interventions

Temozolomide 162 Radiosurgery 115 Radiotherapy 100 Bevacizumab 96 Magnetic Resonance Spectroscopy 65 Carboplatin 48 Etoposide 34 pembrolizumab 33 Surgical Procedures, Operative 33 Irinotecan 33 Nivolumab 32 Cyclophosphamide 32 Erlotinib Hydrochloride 31 Radiation 30 Carmustine 28 Lomustine 25 Cisplatin 25 Trastuzumab 23 Ipilimumab 23 Filgrastim 23 Vincristine 20 Mental Status and Dementia Tests 20 Aminolevulinic Acid 19 Topotecan 18 Pemetrexed 18 Capecitabine 18 Specimen Handling 17 Sorafenib 15 Radiotherapy, Intensity-Modulated 15 Imatinib Mesylate 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Brain Neoplasms × Nutritional Status × Clear all

NCT01770626 2014-10-28

BEAM

University of Alabama at Birmingham

Phase EARLY_PHASE1 Completed

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡